Honing in on Herbal Remedies, Overcoming Obesity, and Drug Therapy Jeopardy

At the completion of this activity, the participant will be able to:

Honing in on Herbal Remedies: Review of Commonly Used Agents

1. Describe the FDA regulatory framework for determining safety, efficacy, and labeling of herbal products.

2. Identify common herbal supplements and their potential therapeutic uses, as well as their associated adverse effects and various interactions with prescription or other over-the-counter medications.

3. Evaluate the safety and effectiveness of herbal supplements using evidence-based resources and patient-specific factors within example cases

Overcoming Obesity: Update on Current and Future Pharmacotherapy Options

1. Describe appropriate patients who may benefit from obesity pharmacotherapy

2. Evaluate common obesity medications with potential therapeutic uses as well as common and severe adverse reactions

3. Identify potential future obesity medication therapies that may offer advantages over current FDA-approved agents

Drug Therapy Jeopardy

1. Identify key laboratory values and parameters for monitoring drug therapy.

2. Describe key characteristics of common drug therapies.

3. Identify clinical pearls from various pharmacotherapy therapies.

Women’s Health and Preventative Medicine

At the completion of this activity, the participant will be able to:

1. Discuss specific patient considerations related to updated pregnancy and lactation guidelines.

2.  Identify key recommendations and updates for contraception, emergency contraception, and pregnancy termination.

3. Describe the guideline recommendations for the management of hormonal replacement therapy in menopausal women.

4. Evaluate the safety and efficacy of the various treatment options for the prevention and management of osteoporosis.

5. Discuss updates in the recommendations for RSV and pneumococcal vaccinations .  

Pharmacogenomics and Updates in Diabetes Management

At the completion of this activity, the participant will be able to:

1. Describe the current framework, recommendations, and evidence to apply patient specific pharmacogenomic information to individualized treatment decisions.

2. Evaluate various drug interactions and patient specific pharmacogenomic drug interaction considerations.

3. Discuss guideline updates in the management of diabetes mellitus, including cardiovascular and renal considerations and their impact on pharmacotherapy selection .

4. Identify how continuous glucose monitors can be utilized to optimize pharmacotherapy regimens for patients with diabetes.

5. Apply the updates discussed for vaccinations, hormonal and osteoporosis therapies, and diabetes management through a series of interactive patient cases and discussions .